97 related articles for article (PubMed ID: 3972759)
1. New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
Lefler E; Stevens DA
J Antimicrob Chemother; 1985 Jan; 15(1):69-75. PubMed ID: 3972759
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
Sobel JD; Muller G
Antimicrob Agents Chemother; 1983 Sep; 24(3):434-6. PubMed ID: 6314893
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental murine aspergillosis with BAY n7133.
Graybill JR; Kaster SR; Drutz DJ
J Infect Dis; 1983 Nov; 148(5):898-906. PubMed ID: 6313822
[TBL] [Abstract][Full Text] [Related]
4. Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis.
Graybill JR; Kaster SR; Drutz DJ
Antimicrob Agents Chemother; 1983 Dec; 24(6):829-34. PubMed ID: 6318660
[TBL] [Abstract][Full Text] [Related]
5. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Odds FC; Webster CE; Abbott AB
J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
[TBL] [Abstract][Full Text] [Related]
6. Azole resistance in Candida albicans.
Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
[TBL] [Abstract][Full Text] [Related]
7. A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
Levine HB
Sabouraudia; 1984; 22(1):37-46. PubMed ID: 6322362
[TBL] [Abstract][Full Text] [Related]
8. Antimycotic activity of BAY N 7133 in animal experiments.
Plempel M
J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018
[TBL] [Abstract][Full Text] [Related]
9. Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
Lefler E; Brummer E; Perlman AM; Stevens DA
Antimicrob Agents Chemother; 1985 Mar; 27(3):363-6. PubMed ID: 3994350
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Troke PF; Andrews RJ; Brammer KW; Marriott MS; Richardson K
Antimicrob Agents Chemother; 1985 Dec; 28(6):815-8. PubMed ID: 3002246
[TBL] [Abstract][Full Text] [Related]
11. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Savani DV; Perfect JR; Cobo LM; Durack DT
Antimicrob Agents Chemother; 1987 Jan; 31(1):6-10. PubMed ID: 3032091
[TBL] [Abstract][Full Text] [Related]
12. Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Ichise K; Tanio T; Saji I; Okuda T
Antimicrob Agents Chemother; 1986 Sep; 30(3):366-9. PubMed ID: 3777903
[TBL] [Abstract][Full Text] [Related]
13. Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Cacciapuoti A; Loebenberg D; Parmegiani R; Antonacci B; Norris C; Moss EL; Menzel F; Yarosh-Tomaine T; Hare RS; Miller GH
Antimicrob Agents Chemother; 1992 Jan; 36(1):64-7. PubMed ID: 1590702
[TBL] [Abstract][Full Text] [Related]
14. Azole resistance in Candida albicans.
Ryley JF; Wilson RG; Barrett-Bee KJ
Sabouraudia; 1984; 22(1):53-63. PubMed ID: 6322363
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the oral triazole antimycotic vibunazole in animals.
Ritter W; Plempel M
J Antimicrob Chemother; 1984 Sep; 14(3):243-52. PubMed ID: 6490569
[TBL] [Abstract][Full Text] [Related]
16. A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.
Martin MV
J Med Vet Mycol; 1989; 27(2):63-70. PubMed ID: 2545852
[TBL] [Abstract][Full Text] [Related]
17. Control of systemic spread of Candida albicans with ketoconazole in the stomachs of mice treated with cytarabine.
Hector RF; Domer JE
J Infect Dis; 1983 May; 147(5):946-50. PubMed ID: 6302178
[TBL] [Abstract][Full Text] [Related]
18. Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis.
Hoeprich PD; Merry JM
Eur J Clin Microbiol; 1985 Aug; 4(4):400-3. PubMed ID: 4043057
[TBL] [Abstract][Full Text] [Related]
19. Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles.
Hughes CE; Beggs WH
J Antimicrob Chemother; 1987 Feb; 19(2):171-4. PubMed ID: 3032882
[TBL] [Abstract][Full Text] [Related]
20. Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
Tucker RM; Hanson LH; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1989 Apr; 33(4):573-5. PubMed ID: 2729949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
